Ask about this productRelated genes to: CD105 antibody
- Gene:
- ENG NIH gene
- Name:
- endoglin
- Previous symbol:
- ORW1, ORW
- Synonyms:
- END, HHT1, CD105
- Chromosome:
- 9q34.11
- Locus Type:
- gene with protein product
- Date approved:
- 1993-03-03
- Date modifiied:
- 2019-04-23
Related products to: CD105 antibody
Related articles to: CD105 antibody
- Hospital wastewater is a significant source of pharmaceutical contaminants, including antipsychotic drugs, which are often inefficiently removed by conventional treatment systems. In this study, the degradation of four antipsychotics was investigated using ozonation and UV-C photolysis under different pH conditions. Kinetic analyses indicated pseudo-first-order behavior, with ozonation achieving faster and more efficient removal compared to photolysis. To complement the evaluation of removal performance, the formation of transformation products (TPs) was assessed. For haloperidol, TPs generated during ozonation were experimentally investigated, while for the other compounds, previously reported TPs from the literature were considered to provide a broader perspective. These compounds were further evaluated using in silico QSAR models to estimate biodegradability and ecotoxicity toward aquatic organisms. The results indicate that although several TPs exhibit increased biodegradability relative to their parent compounds, this trend is not universal and does not consistently translate into reduced ecotoxicity. In the case of haloperidol ozonation, intermediate TPs exhibited a marked increase in predicted toxicity, suggesting that partial oxidation may enhance biological reactivity before subsequent degradation yields less harmful species. Overall, this study highlights that while ozonation is highly effective at removing antipsychotics, assessing TPs is essential for a more comprehensive evaluation of environmental implications. - Source: PubMed
Publication date: 2026/05/15
Reichert Jaqueline FabianeMartins Ayrton FigueiredoFormagini LuanaSouza Darliana Mello - Artificial olfactory systems represent biomimetic platforms that emulate biological olfaction for volatile compound detection and discrimination. Biological olfaction achieves efficient perception through the specific binding of volatile molecules to olfactory receptors (OR), odorant-binding proteins (OBPs), and associated chemosensory proteins, followed by neural encoding, providing a theoretical foundation for artificial olfactory system design. This review synthesizes the current literature sourced from Web of Science, PubMed, and Scopus databases, with selection criteria emphasizing sensing mechanisms, device architectures, and translational applications. Bioelectronic nose platforms utilizing ORs, OBPs, and synthetic peptides are critically evaluated alongside nonbioreceptor-based sensing approaches, specifically colorimetric arrays employing chemo-responsive dyes and metal oxide semiconductor (MOS) sensors, which rely on synthetic rather than biological recognition elements. Four principal application domains constitute the thematic framework: medical diagnosis through breath volatile biomarker detection, food safety assessment via freshness monitoring, environmental surveillance of air and water quality, and public safety applications in hazardous substance detection. Signal processing methodologies encompassing feature extraction and machine learning-based pattern recognition are examined. Critical translational challenges including limited long-term stability of biological recognition elements, sensor drift, and environmental interference are addressed. The comparative analysis indicates that bioreceptor-based platforms achieve superior sensitivity suitable for trace biomarker detection, whereas nonbioreceptor-based sensors offer enhanced operational stability for continuous monitoring, and hybrid architectures integrating biological selectivity with robust synthetic transduction mechanisms represent a promising direction for next-generation devices. - Source: PubMed
Publication date: 2026/05/15
Wang ChongyangWang ZhikaiGan ShengqiHe BinTong YejingwenZhu YaojieYe Dong - Functional electrical stimulation (FES) delivers transcutaneous electrical current to motor nerves to artificially evoke muscle contractions and produce joint torque. In neurorehabilitation, FES is commonly applied via a large surface electrode pair placed over a muscle group-an approach that we here refer to as single-electrode stimulation (SES). However, the torque-generating capacity of SES is limited, possibly due to spatial-fixation of recruited motor units. Targeting specific regions of high electrical excitability, or motor points, may enhance neuromuscular activation and increase joint torque output. - Source: PubMed
Publication date: 2026/05/15
Kozlowski BenjaminLim DerrickGladish MeredithArami ArashMasani Kei - Wind energy has expanded rapidly in recent years, leading to increasingly dense clusters of offshore wind farms. As a result, wind farm wake effects, manifested as reduced wind speeds downstream of operating turbines, have become an important consideration for wind resource assessment and large-scale planning. Here we investigate near-surface wake signatures using wind speeds retrieved from 7122 Sentinel-1A/B synthetic aperture radar (SAR) images acquired between 2020 and 2022, covering more than 60 offshore wind farms across Europe and Asia. A consistent processing workflow and an automated wake-detection algorithm are applied to identify wake-affected regions and quantify wake-related wind speed changes at 10 m height. The results show that near-surface wake signatures can persist over distances exceeding 100 km under favorable conditions and that wake-affected regions exhibit an average wind speed reduction of 0.990 m/s (12.4%) at 10 m height. Several cases of wake interactions extending across national boundaries are also observed in densely developed offshore regions. These findings provide a large-scale, observation-based characterization of near-surface wind farm wake signatures. - Source: PubMed
Publication date: 2026/05/15
Li RuiZhang JinchengZhao Xiaowei - This umbrella review aimed to assess the effectiveness of lower extremity robotic devices in clinical settings by analyzing motor and non-motor rehabilitation outcomes across different neurological conditions, including stroke, spinal cord injury, multiple sclerosis, and Parkinson's disease. - Source: PubMed
Publication date: 2026/05/15
Verrengia Maria GiovannaArcobelli Valerio AntonioLullini GiadaMellone SabatoMazzoleni StefanoChiari LorenzoOrlandi Silvia